Obstructive sleep apnoea and vascular disease in patients with type 2 diabetes

Abd A. Tahrani*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)


Obstructive sleep apnoea (OSA) is common and is associated with many vascular risk factors, such as hypertension, insulin resistance, albuminuria, dyslipidaemia, increased inflammation and endothelial dysfunction. Epidemiological studies have shown that OSA is associated with increased cardiovascular disease (CVD) and that continuous positive airway pressure (CPAP) might reduce CVD events in patients with OSA. In addition, OSA has also been shown to be associated with albuminuria, chronic kidney disease, a wide range of ocular diseases and peripheral neuropathy. Considering that CVD and microvascular complications are major contributors to the morbidity, mortality and the economic burden of diabetes and that OSA is common in patients with type 2 diabetes (T2D), it is important to understand the role of OSA in the development and/or progression of vascular disease in patients with T2D and to explore the impact of CPAP on diabetes-related vascular outcomes. The purpose of this article is to review the evidence for the relationship and impact of OSA on vascular disease and vascular risk factors particularly in patients with T2D.

Original languageEnglish
Pages (from-to)81-89
Number of pages9
JournalEuropean Endocrinology
Issue number2
Publication statusPublished - 2015


  • Obstructive sleep apnoea
  • Type 2 diabetes
  • Vascular disease
  • Vascular risk

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Endocrine and Autonomic Systems


Dive into the research topics of 'Obstructive sleep apnoea and vascular disease in patients with type 2 diabetes'. Together they form a unique fingerprint.

Cite this